Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
2501
DELISTED
NanoString Technologies, Inc.
NSTG
| $191K | ﹤0.01% |
+19,356
| New | +$192K |
|
|
SEMR
2502
DELISTED
Semrush
SEMR
| $189K | ﹤0.01% |
+18,823
| New | +$166K |
|
2503
Grid Dynamics Holdings
GDYN
$630M
| $189K | ﹤0.01% |
+16,500
| New | +$194K |
|
|
ONTF
2504
DELISTED
ON24
ONTF
| $189K | ﹤0.01% |
+21,539
| New | +$190K |
|
|
LGTY
2505
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $188K | ﹤0.01% |
+14,963
| New | +$210K |
|
2506
Mitek Systems
MITK
$836M
| $188K | ﹤0.01% |
+19,638
| New | +$188K |
|
2507
Microvision
MVIS
$86.6M
| $188K | ﹤0.01% |
4,705
+2,563
| +120% | +$97.1K |
|
|
CTIC
2508
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $187K | ﹤0.01% |
44,356
+22,079
| +99% | +$115K |
|
|
WSR
2509
DELISTED
Whitestone REIT
WSR
| $185K | ﹤0.01% |
+20,112
| New | +$195K |
|
|
ICPT
2510
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $184K | ﹤0.01% |
+13,720
| New | +$237K |
|
2511
OraSure Technologies
OSUR
$268M
| $184K | ﹤0.01% |
30,459
+15,900
| +109% | +$89.8K |
|
2512
Mercer International
MERC
$33.5M
| $182K | ﹤0.01% |
+18,650
| New | +$210K |
|
2513
nLIGHT
LASR
$2.84B
| $181K | ﹤0.01% |
+17,756
| New | +$204K |
|
2514
Coherus Oncology
CHRS
$187M
| $181K | ﹤0.01% |
26,419
+14,493
| +122% | +$112K |
|
2515
Allogene Therapeutics
ALLO
$732M
| $180K | ﹤0.01% |
36,433
+20,596
| +130% | +$132K |
|
|
FFIC
2516
DELISTED
Flushing Financial
FFIC
| $178K | ﹤0.01% |
+11,954
| New | +$220K |
|
|
DCPH
2517
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $178K | ﹤0.01% |
+11,504
| New | +$192K |
|
2518
AngioDynamics
ANGO
$651M
| $177K | ﹤0.01% |
+17,210
| New | +$220K |
|
2519
Domo
DOMO
$184M
| $177K | ﹤0.01% |
+12,485
| New | +$176K |
|
2520
Farmers National Banc Corp
FMNB
$952M
| $177K | ﹤0.01% |
+13,983
| New | +$193K |
|
2521
Target Hospitality
TH
$1.66B
| $177K | ﹤0.01% |
+13,475
| New | +$216K |
|
2522
Clear Channel Outdoor Holdings
CCO
$1.23B
| $176K | ﹤0.01% |
147,076
+80,325
| +120% | +$118K |
|
2523
EverQuote
EVER
$884M
| $176K | ﹤0.01% |
+12,623
| New | +$188K |
|
2524
Magnachip Semiconductor
MX
$142M
| $175K | ﹤0.01% |
+18,847
| New | +$187K |
|
2525
AvePoint
AVPT
$2.78B
| $173K | ﹤0.01% |
42,088
+20,879
| +98% | +$94.2K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.